Redox AGM names Mary Verschuer chair: AUD 4.40 target for Redox stock

Published on 10/19/2026 at 01:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Morgan Stanley kept a Hold rating for Redox stock and set an AUD 3.90 target on October 7, 2026. FY26 gross profit reached AUD 298 million.

Growth and board transition

At the October 15, 2026 AGM, Redox reported FY26 sales revenue of AUD 1.33 billion.
Morningstar set an AUD 4.40 fair value estimate on October 8, 2026.
Redox had an AUD 1.8 billion market capitalization as of October 19, 2026.

Redox, AU0000284895, Illustration mit AI erstellt.

Redox (ISIN AU0000284895) reported FY26 sales revenue of AUD 1.33 billion, up 6.90 percent from fiscal 2025, at its October 15, 2026 annual general meeting. Quartr said Mary Verschuer was to succeed Ian Campbell as chair, while Morningstar kept a AUD 4.40 fair value estimate dated October 8, 2026.

FY26 growth strengthens the base

The AGM figures showed gross profit of AUD 298 million in fiscal 2026, up 11.00 percent from the prior year, with gross margin at 22.40 percent. Net profit after tax reached AUD 92 million, an increase of 19.20 percent, according to Quartr.

The operating mix is shifting toward North America. Sales there grew 33.80 percent to more than AUD 100 million in fiscal 2026, while Australian sales rose 6.10 percent to AUD 1.12 billion. That contrast gives the board transition a measurable strategic backdrop.

What does the valuation imply?

Markets Insider reported on October 7, 2026 that Morgan Stanley maintained a Hold rating and set a AUD 3.90 price target. The note also cited quarterly revenue of AUD 656.61 million and net profit of AUD 48.13 million for the quarter ended June 30, 2026.

Three milestones frame the story

On August 20, 2026, Redox released fiscal 2026 results showing revenue of AUD 1.33 billion, according to Simply Wall St. On October 8, 2026, first-quarter fiscal 2027 selling prices were 9.00 percent higher year over year, while volumes were flat, according to Morningstar. On October 15, 2026, the AGM confirmed the chair succession and reviewed fiscal 2026 results.

Redox posted the Dow agency appointment for DOW Latex Powders in Australia and New Zealand on October 5, 2026, according to the company's investor announcements. The October 15, 2026 AGM and the October 5, 2026 agency announcement are the latest dated corporate milestones.

Stock valuation and trading context

The Frankfurt quote was EUR 2.12 on October 16, 2026. Redox's primary listing is on the ASX, where the stock traded at AUD 3.52 at 10:23 a.m. AEDT on October 19, 2026, and its market capitalization was AUD 1.8 billion.

For investors, the central comparison is between durable earnings growth and the cyclical risks described by Morningstar. The fiscal 2026 margin improvement and North American expansion provide measurable support, while flat first-quarter volumes keep the near-term operating picture mixed.

Board change meets earnings growth

Redox enters the new chair's tenure with fiscal 2026 revenue growth of 6.90 percent, net profit growth of 19.20 percent and a 22.40 percent gross margin. The last Frankfurt quote was EUR 2.12 on October 16, 2026.